`571.272.7822 Entered: September 24, 2018
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`AUROBINDO PHARMA USA, INC.
`Petitioner,
`
`v.
`
`ANDRX CORPORATION,
`ANDRX LABORATORIES, INC.
`ANDRX LABORATORIES (NJ), INC.
`ANDRX EU LTD.
`ANDRX PHARMACEUTICALS, LLC,
`TEVA PHARMACEUTICAL INDUSTRIES LTD.
` Patent Owners.
`____________
`
`Case IPR2017-01648
`Patent 6,866,866
`____________
`
`
`Before JACQUELINE WRIGHT BONILLA, Acting Deputy Chief Administrative
`Patent Judge.
`
`
`
`
`
`
`PANEL CHANGE ORDER
`Conduct of the Proceedings
`37 C.F.R. § 42.5
`
`
`
`
`
`IPR2017-01648
`Patent 6,866,866
`
`
`The parties are notified that the panel has changed in the above referenced
`proceeding. See PTAB Standard Operating Procedure 1, Rev. 15. Due to
`unavailability, Administrative Patent Judge Jo-Anne M. Kokoski replaces
`Administrative Patent Judge Tina Hulse on the panel.
`Thus, Administrative Patent Judges Susan L. C. Mitchell, Jo-Anne M.
`Kokoski, and Devon Zastrow Newman now constitute the panel for consideration
`of all matters in this proceeding. See PTAB Standard Operating Procedure 1, Rev.
`15. All prior decisions and orders remain in effect. The parties may contact the
`Board at Trials@uspto.gov if they have questions.
`It is
`ORDERED.
`
`
`
`
`
`
`
`
`
`
`
`IPR2017-01648
`Patent 6,866,866
`
`PETITIONER:
`
`Steven J. Moore
`John Winterle
`Hans Peter Hoffmann
`Alan Gardner
`WITHERS BERGMAN LLP
`steven.moore@withersworldwide.com
`john.winterle@withersworldwide.com
`peter.hoffmann@withersworldwide.com
`alan.gardner@withersworldwide.com
`IPG-AUR@withersworldwide.com
`
`PATENT OWNER:
`
`David L. Cavanaugh
`Jonathan Ben-Ur Roses
`WILMER HALE
`david.cavanaugh@wilmerhale.com
`jonathan.roses@wilmerhale.com
`
`
`
`
`
`
`
`
`